Prognostic impact of nodal statuses in patients with pancreatic ductal adenocarcinoma
- 1 March 2017
- journal article
- Published by Elsevier in Pancreatology
- Vol. 17 (2) , 279-284
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus GemcitabineNew England Journal of Medicine, 2013
- Pancreatic Cancer Surgery in the New MillenniumAnnals of Surgery, 2011
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic CancerNew England Journal of Medicine, 2011
- The Lymph Node Ratio is the Strongest Prognostic Factor after Resection of Pancreatic CancerJournal of Gastrointestinal Surgery, 2009
- Prognostic Significance of Pathologic Nodal Status in Patients with Resected Pancreatic CancerJournal of Gastrointestinal Surgery, 2007
- Impact of Total Lymph Node Count and Lymph Node Ratio on Staging and Survival after Pancreatectomy for Pancreatic Adenocarcinoma: A Large, Population-Based AnalysisAnnals of Surgical Oncology, 2007
- The Ratio of Metastatic/Resected Lymph Nodes is an Independent Prognostic Factor in Patients With Node-positive Pancreatic Head CancerPancreas, 2006
- Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinomaBritish Journal of Surgery, 2004
- Resected adenocarcinoma of the pancreas—616 patients: results, outcomes, and prognostic indicatorsJournal of Gastrointestinal Surgery, 2000
- Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: Postoperative Adjuvant Chemoradiation Improves SurvivalAnnals of Surgery, 1997